Queens Cancer Center Minority-Based Community Clinical Oncology Program

描述（由申请人提供）：皇后癌症中心（QCC）少数族裔社区临床肿瘤学项目（MBCCOP）是美国国立卫生研究院（NIH）资助的第一个项目，授予纽约市的公立医院系统，即卫生与医院公司（HHC）。QCC是皇后健康网络（QHN）的一部分，该网络由皇后区仅有的两家公立医院，皇后医院中心（QHC）和埃尔姆赫斯特医院中心（EHC）组成。由于QHN的人口中有92%是少数民族，我们是唯一有资格参加这个少数民族项目的人。自2002年成立以来，QCC一直致力于为皇后区以前服务不足的人提供最好的癌症治疗，包括少数族裔患者、新移民和没有保险或经济能力的患者。皇后健康网络服务的人群有各种晚期癌症的不幸历史。贫困的生存。QCC的使命是降低晚期癌症的发病率，改善对癌症的护理。实现这一目标的战略包括社区教育、引入癌症控制试验、早期推广

DESCRIPTION (provided by applicant): The Queens Cancer Center (QCC) Minority-Based Community Clinical Oncology Program (MBCCOP) is the first National Institute of Health (NIH) funded grant, awarded to the public hospital system of New York City known as the Health and Hospital Corporation (HHC). QCC is part of the Queens Health Network (QHN) which is comprised of the only two public hospitals in Queens, Queens Hospital Center (QHC) and Elmhurst Hospital Center (EHC). Since the population of QHN is 92% minorities, we are uniquely qualified for this minority program. Since its inception in 2002, the QCC has been dedicated to bringing the best possible cancer care to the people in Queens who were previously underserved, including minority patients, recent immigrants and patients without insurance or means. The population served by the Queens Health Network has an unfortunate history of late stage cancers of all kind and. poorer survival. The mission of QCC is to reduce the rate of late stage disease and to improve the care for cancer. The strategies to accomplish this includes education of the community, introduction of cancer control trials, outreach for early detection programs and state of the art cancer care including access to cancer treatment trials. The patient population of QHN is overwhelmingly from minority groups who usually do not have access to clinical trials. The QHN is the only health facility in Queens, a borough more than 2 million people that offers access to multi-institutional treatment trials. Since the MBCCOP was awarded (September of 2010) the infrastructure was put in place to combine the resources of both centers (QHC and EHC) to assure access of patients to appropriate clinical trials. The process has been slow and is still evolving. It required hiring research staff and developing a quality training program in areas where previously no research was in place. We now have the staff and infrastructure in place to carry out the mission of MBCCOP going forward to increase access to clinical trials for our patients.